All News

Patients with locally advanced muscle-invasive bladder cancer may benefit from dose-dense gemcitabine and cisplatin.

My local Gilda’s Club chapter helped me through cancer, so I continued to go after finishing treatment

Olomorasib plus Keytruda was proven to be safe and well tolerated for patients with KRAS G12C-mutant non-small cell lung cancer.

After a decade of surviving cancer, I’ve wondered if it’s possible to truly forget I had breast cancer. After a small incident, I thought perhaps it was possible. Now I’m not so sure.

Levels of tumor-infiltrating lymphocytes in patients with stage 1 triple-negative breast cancer may be a biomarker to help with optimized treatment plans.

Helping others through their cancer experience helped with my own feelings of survivor's guilt.

With attitudes evolving around telemedicine in oncology, one doctor explains how patients can get ready for a video appointment with their provider.

After my myeloma diagnosis, each day is my own personal Olympics, filled with trials and triumph.

One researcher explains the science behind Lymphir, recently approved by the FDA for relapsed/refractory cutaneous T-cell lymphoma.

Even though my wife became quadriplegic after her breast cancer progressed, our insurance still did not help us out, so I became her caregiver full-time.

Walking up and down the street a few times a day can help prevent patients with kidney or bladder cancers from becoming deconditioned.

During chemotherapy for my chronic lymphocytic leukemia, I try my best to appreciate the positive aspects of life, like flowers and friends.

One expert explains how a break in TKI treatment could alleviate some toxicities, such as rash, for patients with non-small cell lung cancer.

Just like athletes in the Olympics, it's important for cancer survivors to keep track of everything they feel and to know their bodies well.

From Patti Yasutake’s death from cancer to Olympic water polo player’s husband’s rare cancer diagnosis, here’s what’s happening in the oncology space this week.

An expert explained the importance of understanding different subtypes of metastatic breast cancer and available treatment options based on biomarker testing.

Through colon cancer and liver cancer, faith is what brought me to peace and clarity during treatment and now survivorship.

For patients with glioblastoma, collecting information about their disease and treatment options is important before providing informed consent.

When I started experiencing symptoms of an infection, I was worried that my follicular lymphoma had returned.

The cancer vaccine, mRNA-4157, garnered immune responses of 30 weeks among some patients with melanoma and lung cancer, study results showed.

Lymphir, an immunotherapy, has been approved by the FDA to treat patients with relapsed or refractory cutaneous T-cell lymphoma.

The National Comprehensive Cancer Network now recommends Rytelo for patients with myelodysplastic syndrome who require blood transfusions.

The FDA will review an application for Cabometyx as a potential treatment for pancreatic neuroendocrine tumors after findings from a phase 3 trial.

After receiving cancer treatment and leaving the hospital, sometimes it feels like a safety net has been pulled away and loneliness sets in.

Interventions, such as speech therapy, after receiving radioactive iodine treatment for thyroid cancer may help manage quality of life.

During my chemotherapy treatments for chronic lymphocytic leukemia, I had a supportive group of people surrounding me.

The FDA has approved Voranigo to treat certain patients with grade 2 astrocytoma or oligodendroglioma with select mutations, following surgery.

Patients with blood cancer who undergo CAR-T cell therapy should monitor for fever and signs of respiratory distress, an expert said.